Two losses. Three losses. Each one experienced with the same grief, the same shock, and the same desperate question: why does this keep happening? Recurrent pregnancy loss is one of the most emotionally devastating experiences in reproductive medicine. For the 1 to 5% of couples who experience it, each loss does not simply represent a clinical event. It represents a baby, a future, and a profound disruption to everything a family was building toward.
The most important thing the current evidence on recurrent pregnancy loss management tells us is that it is not simply bad luck. In the majority of couples with RPL, structured investigation reveals at least one contributing cause. Many of those causes are correctable. And among the most consistently correctable causes are lifestyle factors: modifiable, within a woman's and couple's control, and addressed through changes that are sustainable before and during a next pregnancy.
This guide explains what the latest international guidelines recommend, which lifestyle changes carry the strongest evidence, and how they fit into a comprehensive recurrent pregnancy loss management plan.
What Is Recurrent Pregnancy Loss?
Recurrent pregnancy loss is defined as two or more pregnancy losses before viability. The December 2025 SOGC Guideline No. 464, the most recently published international clinical guideline on this condition, aligns with the definition of two or more losses before 20 weeks of gestation, including non-consecutive and biochemical (very early) losses.
This updated definition is clinically significant. The historical requirement of three consecutive losses before investigation was warranted has been replaced by the recognition that two losses justify investigation. The rationale is clear: the emotional burden of each additional loss while awaiting the qualifying threshold is significant and the delay in identifying a treatable cause is clinically unjustified.
Recurrent pregnancy loss is a significant reproductive challenge with profound emotional, physical, and psychological impact. Management requires a caring, evidence-based medical approach with a thorough understanding of this multifactorial condition.
The known causes of recurrent pregnancy loss include:
-
Chromosomal or genetic factors in either partner or in the pregnancy itself
-
Anatomical uterine abnormalities (septum, polyps, fibroids, adhesions)
-
Antiphospholipid syndrome (APS), the most important treatable immunological cause
-
Inherited and acquired thrombophilias
-
Endocrine disorders: thyroid dysfunction, diabetes, PCOS
-
Uterine infection or chronic endometritis
-
Lifestyle and environmental factors
-
Male factor (sperm DNA fragmentation)
Despite thorough investigation, approximately 50% of cases remain unexplained. Even unexplained RPL carries a meaningful chance of successful subsequent pregnancy, which the 2024 Australasian ACCEPT guideline placed at 65 to 75% with appropriate supportive care.
Why Lifestyle Factors Matter in Recurrent Pregnancy Loss Management
Lifestyle factors have a unique place in RPL management because they are modifiable. Unlike chromosomal causes or structural uterine abnormalities that require specialist intervention, many lifestyle-related contributing factors can be directly addressed by the couple themselves, with professional guidance.
The 2024 Australasian CREI Consensus Expert Panel on Trial Evidence (ACCEPT) Guideline Part II specifically reviewed environmental and lifestyle factors in RPL. As most of these factors are exposure related and therefore modifiable, the guideline consistently recommends cessation of smoking and alcohol consumption while limiting caffeine intake. The December 2025 SOGC Guideline No. 464 further specified reducing caffeine, stopping smoking and alcohol, and addressing obesity as core management strategies.
These recommendations are not speculative wellness advice. They are grounded in the mechanistic understanding of how each lifestyle factor affects implantation, placentation, chromosomal integrity, hormonal regulation, and immune function in early pregnancy.
Smoking Cessation
Smoking is one of the most consistently identified modifiable risk factors for spontaneous pregnancy loss and for recurrent pregnancy loss specifically.
The mechanisms are multiple and converging:
-
Tobacco smoke contains approximately 7,000 chemicals, many of which are directly mutagenic to egg and sperm DNA
-
Carbon monoxide from tobacco reduces oxygen delivery to the developing embryo
-
Nicotine and cotinine reduce blood flow to the uterus and endometrium, impairing implantation
-
Smoking accelerates ovarian ageing, reducing the quality of eggs available for conception
-
Both active smoking and passive (secondhand smoke) exposure are associated with elevated miscarriage risk
The 2024 Australasian ACCEPT guideline identifies smoking as a modifiable environmental factor with consistent evidence for increased pregnancy loss risk. Cessation is recommended for both partners in couples experiencing RPL.
The specific benefit of cessation before the next conception attempt rather than after a positive pregnancy test reflects the timeframe of early embryonic development. The critical period of embryonic organogenesis begins before many women know they are pregnant. Pre-conception smoking cessation protects the embryo from the earliest days.
Cessation support including nicotine replacement therapy (NRT), varenicline, and behavioural counselling significantly improves success rates compared to willpower alone. NRT is preferred over continued smoking during a pregnancy attempt. Varenicline should be discontinued once pregnancy is confirmed.
Alcohol Elimination
All major current guidelines on recurrent pregnancy loss management include alcohol elimination as an unambiguous recommendation.
Alcohol is a direct teratogen. It crosses the placental barrier from the earliest weeks of pregnancy, before most women are aware they are pregnant. Ethanol and its metabolite acetaldehyde are embryotoxic, damaging rapidly dividing cells in the developing embryo and disrupting cellular signalling pathways that regulate normal development.
The dose-response relationship between alcohol and miscarriage risk is well-documented:
-
Even low to moderate alcohol consumption (one to two drinks per week) is associated with measurably increased miscarriage risk in studies of large populations
-
Binge drinking (four or more drinks on a single occasion) is strongly associated with first-trimester loss
-
There is no established safe level of alcohol in early pregnancy
The March 2025 Canadian Fertility and Andrology Society clinical practice guideline on recurrent early pregnancy loss specifically includes alcohol cessation as part of the modifiable risk factor assessment and management plan.
For couples experiencing recurrent pregnancy loss, the recommendation is complete abstinence from alcohol from the point of decision to attempt another pregnancy, not from the point of a positive test. This removes the risk during the pre-implantation and early embryonic period when fetal alcohol effects are most severe.
Caffeine Reduction
The relationship between caffeine and pregnancy loss is more nuanced than smoking and alcohol, but sufficiently evidenced to warrant a clear recommendation.
Caffeine is a methylxanthine that crosses the placental barrier. The embryo and early fetus lack the enzyme (CYP1A2) to metabolise caffeine effectively, meaning caffeine and its metabolites accumulate in fetal tissues at concentrations higher than in the mother. Caffeine reduces uterine blood flow and has vasoconstrictor properties that may impair placental perfusion.
Multiple large cohort studies have found a dose-dependent association between caffeine intake and miscarriage risk, with the association becoming statistically significant above 200 mg per day.
The December 2025 SOGC Guideline No. 464 recommends reducing caffeine intake as a lifestyle management strategy for RPL. The 200 mg per day threshold corresponds approximately to:
-
One large mug of filter coffee (approximately 140 to 200 mg)
-
Two cups of standard brewed tea (approximately 90 to 100 mg total)
-
One can of cola (approximately 35 to 40 mg)
Practical guidance for couples experiencing RPL:
-
Reduce total daily caffeine below 200 mg from all sources
-
Switch afternoon and evening coffees to decaffeinated versions or herbal alternatives
-
Count caffeine from chocolate, energy drinks, and soft drinks alongside coffee and tea
-
Both partners should reduce caffeine, as paternal caffeine intake at high levels may affect sperm quality
Weight Management and BMI Optimisation
Maternal obesity is associated with a higher risk of recurrent pregnancy loss. The 2025 plain language summary of the ACCEPT guideline states this association directly. The mechanism involves several overlapping pathways:
-
Obesity drives insulin resistance, which elevates insulin and LH levels that impair ovarian function and oocyte quality
-
Increased circulating androgens in obese women with PCOS impair endometrial receptivity
-
Systemic chronic low-grade inflammation from excess adipose tissue creates a hostile implantation environment
-
Obese women have higher rates of chromosomally abnormal conceptions through mechanisms related to oocyte mitochondrial dysfunction
-
Elevated oestrogen from peripheral conversion in adipose tissue disrupts the endocrine environment of early pregnancy
Weight loss of 5 to 10% of body weight in overweight or obese women before the next conception attempt produces measurable improvements in hormonal profile, ovulatory function, and pregnancy outcomes.
Equally, underweight status and significantly low BMI are associated with impaired fertility and pregnancy loss through insufficient nutritional reserves, hormonal disruption from energy deficiency, and reduced endometrial development.
The target is a BMI in the healthy range (18.5 to 24.9 by standard classification, with a lower threshold of 23 for South Asian women where metabolic risk is elevated at lower BMIs). For women managing PCOS alongside RPL, the ACCEPT guideline specifically recommends a personalised approach that may include metformin as well as lifestyle changes including a healthy diet and exercise to improve pregnancy outcomes.
Nutritional Optimisation Before and During Pregnancy
The role of specific micronutrients in early pregnancy development and in miscarriage prevention has been studied extensively, and several specific nutritional recommendations emerge from this evidence base.
Folic Acid
Folic acid supplementation from at least one month before conception and through the first 12 weeks of pregnancy reduces the risk of neural tube defects. For women with RPL, the standard recommendation is 400 mcg daily (5 mg daily for women with a previous neural tube defect pregnancy, those on anti-epileptic medication, or those with a BMI above 30).
Methylfolate supplementation has been proposed as an alternative for women with MTHFR gene variants that impair folic acid metabolism, though the clinical evidence for a specific benefit of methylfolate over standard folic acid in RPL is still developing.
Vitamin D
Vitamin D deficiency is extremely prevalent in India and is associated with adverse pregnancy outcomes including miscarriage. Vitamin D receptors are expressed in decidual and trophoblastic cells, and adequate vitamin D supports the immunological tolerance that is required for successful implantation and placentation.
Testing vitamin D status and supplementing identified deficiency before conception and throughout pregnancy is a practical, low-risk intervention recommended as part of preconception optimisation in couples with RPL.
Omega-3 Fatty Acids
Omega-3 fatty acids, particularly DHA and EPA from oily fish or supplementation, have anti-inflammatory effects that may support the immune tolerance required for successful pregnancy continuation. Emerging evidence links omega-3 supplementation with reduced early pregnancy loss, though this is not yet a strong-grade guideline recommendation. Including oily fish two to three times a week in the preconception diet is a reasonable, safe, and nutritionally supportive choice.
Antioxidants
Oxidative stress is increasingly recognised as a contributor to embryonic and placental damage in early pregnancy loss. Antioxidant nutrients including vitamin C, vitamin E, selenium, and coenzyme Q10 may support mitochondrial health in oocytes and early embryos. Coenzyme Q10 supplementation is particularly discussed in the context of advancing maternal age and oocyte quality.
Managing Stress and Psychological Wellbeing
The psychological burden of recurrent pregnancy loss is one of its most significant and most consistently underserved dimensions. Women with recurrent miscarriage have measurably higher rates of anxiety, depression, and post-traumatic stress symptoms than the general population, and these psychological responses are entirely understandable responses to profound, repeated loss rather than weaknesses to be managed away.
The clinical relevance of psychological stress in RPL extends beyond the obvious emotional dimension. Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol and other stress hormones that affect reproductive hormone profiles, uterine blood flow, and implantation. Whether stress is a direct cause of miscarriage or primarily a consequence of the losses is a question the evidence does not fully resolve, but addressing psychological wellbeing is clinically appropriate on multiple grounds.
The 2024 Australasian ACCEPT guideline recommends psychological support and emotional care as components of RPL management alongside medical investigation. The December 2025 SOGC Guideline No. 464 similarly emphasises the profound emotional, physical, and psychological impact of RPL as requiring a caring approach.
Practical psychological support approaches in RPL management:
-
Dedicated specialist follow-up between pregnancy attempts rather than only during pregnancies
-
Early reassurance ultrasound in subsequent pregnancies for couples with anxiety about recurrence
-
Psychological therapy including CBT for anxiety and depression where these develop
-
Access to peer support communities of others who have experienced pregnancy loss
-
Partner inclusion in consultations and in acknowledgement of the couple's shared loss
-
Clear communication about investigation findings and management plans, reducing the uncertainty that amplifies anxiety
Environmental Factors and Endocrine-Disrupting Chemicals
The 2024 Australasian ACCEPT guideline Part II specifically identifies endocrine-disrupting chemicals (EDCs) as environmental factors associated with increased RPL risk. EDCs are substances that interfere with hormone synthesis, metabolism, or action, resulting in deviation from normal hormonal function.
Sources of EDC exposure in everyday life include:
-
Bisphenol A (BPA) and phthalates in plastic containers, particularly when used with hot liquids or food
-
Parabens in cosmetics, skin care, and personal care products
-
Pesticide residues on conventionally grown produce
-
Industrial chemicals in occupational settings (certain manufacturing, agricultural, and chemical industries)
Practical reduction strategies:
-
Choose glass, stainless steel, or BPA-free containers for hot food and drinks
-
Choose fresh or frozen produce over canned where possible
-
Wash all fruit and vegetables thoroughly before consumption
-
Review personal care products for parabens and phthalates
-
Be aware of occupational exposures and ensure appropriate protective measures
The evidence for specific EDCs and RPL risk is not yet at the level of smoking or alcohol, but given that these are modifiable exposures with plausible mechanistic pathways, reducing them before and during pregnancy is a precautionary measure with no meaningful risk.
Exercise and Physical Activity
Regular moderate-intensity exercise is beneficial in the preconception period for women with RPL. The benefits include improved insulin sensitivity, weight management, reduction in systemic inflammation, improved psychological wellbeing, and better sleep quality.
The emphasis is on moderate-intensity exercise. Very high-intensity exercise and excessive training loads, particularly in women with low body weight, can suppress reproductive hormonal function and impair ovulation. This is not a reason to avoid exercise but a reason to calibrate intensity appropriately.
A practical target of 150 minutes per week of moderate-intensity aerobic exercise (brisk walking, swimming, cycling, yoga) alongside two sessions of strength or resistance training provides the cardiovascular and metabolic benefits without the reproductive suppression risk of extreme exercise.
Male Factor: Both Partners Matter
Recurrent pregnancy loss management must address both partners, not only the woman. Sperm DNA fragmentation, where the DNA within sperm cells is damaged or broken, is increasingly recognised as a contributor to early pregnancy loss.
High levels of sperm DNA damage are associated with reduced fertilisation rates, impaired embryo development, and increased early pregnancy loss. Male lifestyle factors that increase sperm DNA fragmentation include:
-
Smoking
-
Excess alcohol
-
High scrotal temperature from hot baths, saunas, or tight clothing
-
Obesity
-
Excessive reactive oxygen species from environmental toxin exposure
-
Anabolic steroid use
The same lifestyle changes recommended for the female partner, particularly smoking cessation, alcohol reduction, caffeine reduction, and weight management, are equally relevant for the male partner and should be addressed together as a couple's management plan rather than solely as a female health issue.
Medical Investigation That Lifestyle Changes Cannot Replace
Lifestyle modification is a core component of recurrent pregnancy loss management but it is not the whole management plan. Structural, immunological, endocrine, and genetic causes require specialist medical investigation regardless of how well lifestyle has been optimised.
The current guidelines recommend investigation for:
-
Antiphospholipid syndrome (APS): the most important treatable immunological cause, identified by anticardiolipin antibody, anti-beta2 glycoprotein I antibody, and lupus anticoagulant testing
-
Uterine anatomy: hysteroscopy or saline infusion sonography to assess for septum, polyps, fibroids, and adhesions
-
Thyroid function: TSH and anti-TPO antibodies; target TSH below 2.5 mIU/L before conception
-
Blood glucose and HbA1c: poorly controlled diabetes is a significant RPL risk factor
-
Parental karyotyping: identified chromosomal rearrangements in either partner explain some RPL cases and guide further fertility management
-
Sperm DNA fragmentation testing for the male partner
Treatment of antiphospholipid syndrome with low-dose aspirin and low molecular weight heparin in subsequent pregnancy is one of the most well-evidenced specific treatments in RPL management, producing significantly improved live birth rates in APS-positive couples.
Care at Humayun Hospital, T Nagar
At Humayun Hospital, T Nagar, Chennai, Dr. Asma Humayun provides comprehensive recurrent pregnancy loss assessment, investigation, and management for couples who have experienced two or more pregnancy losses.
Dr. Asma Humayun is a Gynaecologist and Obstetrician with over 15 years of clinical experience, holding MBBS, DGO (Sri Ramachandra University), Fellowship in Assisted Reproductive Techniques (F.ART), Fellowship in Minimal Access Surgery (F.MAS), Diploma in Reproductive Medicine from Germany, and MRCOG (Royal College of Obstetricians and Gynaecologists, UK). Her Fellowship in Reproductive Medicine and her ART training give her specific clinical depth in the investigation and management of recurrent pregnancy loss, including the fertility implications of identified causes.
We offer:
-
Detailed clinical history and RPL investigation planning based on the December 2025 SOGC guideline framework
-
Blood testing for antiphospholipid syndrome, thrombophilia, thyroid function, blood glucose, and hormonal profile
-
Pelvic ultrasound, saline infusion sonography, and hysteroscopy for uterine structural assessment
-
Parental karyotyping referral where chromosomal rearrangement is suspected
-
Sperm DNA fragmentation testing referral for the male partner
-
Personalised lifestyle modification guidance covering smoking, alcohol, caffeine, weight, nutrition, and environmental factors
-
Medical treatment for identified causes including low-dose aspirin and LMWH for APS, thyroid optimisation, metformin for insulin resistance and PCOS
-
Early pregnancy support and reassurance ultrasound in subsequent pregnancies
-
Psychological support awareness and referral for couples requiring dedicated counselling
Recurrent pregnancy loss is not something to manage alone or to accept without investigation. With the right assessment and the right support, the large majority of couples with RPL go on to have a successful pregnancy.
Chat with our medical assistant for quick guidance and support.
